Latest Drug Coverage news from across the web.
Under the Affordable Care Act, most women are entitled to one fully covered annual wellness visit with no copay or deductible. Yet today these visits often leave women without complete answers to their symptoms or surprise bills, Visana executives say.
Read full article →Similar to its for-profit peer HCA Healthcare, CHS said "an unfavorable change" in payer mix played a role in this quarter's numbers.
Read full article →Access to medications for opioid use disorder, considered the gold standard of care, is poor on average and even worse in underserved settings. Boulder will design and deliver special care pathways across five such settings.
Read full article →The Trump administration will appeal a Georgia court ruling that led it to broadly recalculate insurers' Medicare Advantage star ratings scores for 2026.
Read full article →The agency took another step toward codifying and enacting provider tax thresholds outlined in last summer's One Big Beautiful Bill Act.
Read full article →The company says its RCM platform, which leverages advanced automation to decrease the cost to collect and increase net collection rates, is now used by more than 200 healthcare organizations.
Read full article →The tentative deal includes a $2 billion strategic capital commitment from Prisma and would yield a 27-hospital, $9 billion operating revenue nonprofit in the southeast.
Read full article →The tool, dubbed Samsung Health Assistant, allows users to ask questions and receive personalized guidance and recommendations in the Samsung Health app.
Read full article →The company plans to use the funding to expand research and development and go-to-market teams, Assured Co-Founder and President Rahul Shivkumar told Fierce Healthcare.
Read full article →Fewer women are beginning prenatal care in the first trimester, while more are entering care later or not at all. Unified Women’s Healthcare Chief Medical Officer Elizabeth Cherot, M.D., discusses what is driving the decline and how technology, care coordination and stronger patient trust could help expand access.
Read full article →A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifepristone.
Read full article →As part of the Trump administration's ongoing war on fraud, waste and abuse in healthcare, a new report looks at how states can improve the volume of fraud referrals from managed care organizations.
Read full article →